Revenue was $67.2 million, a 15% decrease year-over-year, but a 7% increase compared to the second quarter of 2023, excluding Medicare claims billing adjustments.

Testing Services patient results grew to 38,400, a 2% increase compared to the second quarter of 2023.

Digital Solutions and Products revenue reached $9.9 million and $9.5 million, respectively, representing a 33% year-over-year growth for both.

Cash and cash equivalents and marketable securities totaled $268.2 million with no debt.